Abstract
Trials on the effect of systemic chemotherapy on survival and recurrence in adults with high-grade glioma have had inconclusive results. We undertook a systematic review and meta-analysis to assess the effects of such treatment on survival and recurrence. METHODS: We did a systematic review and meta-analysis using updated data on individual patients from all available randomised trials that compared radiotherapy alone with radiotherapy plus chemotherapy. Data for 3004 patients from 12 randomised controlled trials were included (11 published and one unpublished). FINDINGS: Overall, the results showed significant prolongation of survival associated with chemotherapy, with a hazard ratio of 0.85 (95% CI 0.78-0.91, p
| Original language | English |
|---|---|
| Pages (from-to) | 1011-1018 |
| Number of pages | 7 |
| Journal | The Lancet |
| Volume | 359 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 1 Apr 2002 |